Skip to main content

Richard Pizzi

By Richard Pizzi | 10:18 am | December 03, 2010
Online advertised vacancies for healthcare practitioners and technical occupations increased in November, while demand for healthcare support personnel remained steady.
By Richard Pizzi | 02:35 pm | December 01, 2010
Healthcare in the United States is becoming increasingly unaffordable, and one of the contributing factors may be the high salaries earned by healthcare employees.
By Richard Pizzi | 02:18 pm | December 01, 2010
In the midst of recession and widespread uncertainty about the implications of healthcare reform, hospitals across the United States were forced in 2010 to implement innovative purchasing strategies to help cut costs.
By Richard Pizzi | 10:33 am | December 01, 2010
The University of Maryland Medical Center in Baltimore and Virginia Mason Medical Center in Seattle have been named "Top Hospitals of the Decade" by The Leapfrog Group.
By Richard Pizzi | 10:30 am | November 29, 2010
Thomson Reuters has acquired GeneGo, a provider of biology and disease information, analytics and decision support services for pharmaceutical research and development.
By Richard Pizzi | 12:14 pm | November 24, 2010
Online advertised vacancies for healthcare practitioners, technical occupations and support personnel increased significantly in October.
By Richard Pizzi | 11:15 am | November 23, 2010
Diabetes care for Native Americans is significantly underfunded, although that population has the highest per capita incidence of diabetes in the United States.
By Richard Pizzi | 11:10 am | November 22, 2010
Fitch Ratings has downgraded the credit rating on more than $200 million in revenue bonds issued on behalf of the Nebraska Methodist Health System, a three-hospital system based in Omaha, Neb.
By Richard Pizzi | 10:17 am | November 19, 2010
The average per capita cost of healthcare services covered by commercial insurance and Medicare rose 7.08 percent over the past 12 months, according to data released this week by Standard & Poor's.
By Richard Pizzi | 11:15 am | November 17, 2010
Moody's Investor's Service predicts that the outlook for the global pharmaceutical industry remains negative, primarily due to the sector's increasing exposure to major patent expirations.